Applications of aptamers in drug delivery system
Journal name: World Journal of Pharmaceutical Research
Original article title: Applications of aptamers in drug delivery system
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Yujie Jiang, Chenchen Xu, Shuyi Li, Jinlong Yang, Zhenghong Wu and Xiaole Qi
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Applications of aptamers in drug delivery system
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20175-8432
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
Aptamers are short, single-stranded oligonucleic acids that can bind to various target molecules with high specificity and affinity, making them promising tools in cancer diagnostics and drug delivery systems. Utilizing the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) approach, aptamers can be identified and produced to target proteins, peptides, and cells. Their advantages over traditional ligands, such as antibodies—including lower immunogenicity and higher specificity—have inspired significant research into their applications, especially in cancer treatment.
SELEX Process
The SELEX process is a vital method for generating aptamers, involving an iterative in vitro evolution procedure. It starts with a random library of DNA oligonucleotides, which is exposed to target molecules. After the unbound sequences are removed, the bound sequences are amplified, and this process is repeated to enrich the pool for aptamers that specifically bind to the target. Ultimately, successful aptamer candidates are identified through cloning and sequencing. This robust method allows the generation of aptamers that exhibit high binding affinity to various targets, paving the way for their therapeutic applications.
Aptamers in Cancer Diagnostics
Due to their specificity and versatility, aptamers have significant potential in cancer diagnostics. Research has developed innovative detection methods using aptamer-conjugated nanoparticles, such as colorimetric assays with gold nanoparticles (GNPs) that reveal a color change upon interaction with diseased cells, allowing for easy visual detection. Additionally, quantitative detection methods using QD-labeled aptamers offer a precise means to identify cancer markers, demonstrating the effectiveness of aptamers in creating sensitive and efficient diagnostic tools for early cancer detection.
Aptamer-Mediated Drug Delivery Systems
The functionalization of various nanoparticles with aptamers has led to advanced targeted drug delivery systems, significantly enhancing precision in cancer therapy. Aptamer-drug nanoparticles can effectively deliver chemotherapeutic agents to cancer cells, minimizing side effects in non-tumor tissues. Additionally, conjugation techniques—both covalent and noncovalent—allow for high drug-loading capabilities while maintaining drug activity. Aptamers conjugated with quantum dots and gold nanoparticles have also shown promise in delivering and releasing drugs in response to specific biological stimuli, further showcasing their potential as vehicles for targeted therapy.
Conclusion
In conclusion, aptamers represent a powerful class of ligands with unique properties that facilitate their use in cancer diagnostics and targeted drug delivery systems. Their low immunogenicity, high specificity, and versatility in conjugation techniques offer promising avenues for cancer treatment advancements. As research continues to explore and refine aptamer applications, they are likely to play a crucial role in the development of novel therapeutic strategies, bringing hope for improved cancer management in the future.
FAQ section (important questions/answers):
What are aptamers and why are they important in drug delivery?
Aptamers are short single-stranded oligonucleic acids or peptides that bind target molecules with high specificity and affinity. They have advantages over antibodies, such as lower immunogenicity and high binding specificity, making them valuable tools in cancer diagnostics and drug delivery systems.
What is the SELEX process used for aptamer selection?
The SELEX process, or systematic evolution of ligands by exponential enrichment, is an iterative in vitro method designed to identify aptamers from large pools of oligonucleotides. This process enriches aptamers that bind specifically to target molecules, allowing for precise identification of binding sequences.
How are aptamers utilized in cancer diagnostics?
Aptamers can selectively recognize cancer-specific markers, enabling accurate and rapid cancer detection methods. They have been used to develop colorimetric assays, fluorescence-based detection systems, and imaging probes that enhance diagnostic capabilities for various types of cancer.
What role do nanoparticles play in conjunction with aptamers?
Nanoparticles, such as gold nanoparticles and quantum dots, enhance the functionality of aptamers by providing targeted drug delivery and detection. They can be conjugated with aptamers, allowing for precise targeting of cancer cells and improved therapeutic delivery systems.
What are the benefits of aptamer-drug nanoparticles?
Aptamer-drug nanoparticles facilitate targeted delivery of therapeutic agents while protecting their bioactivity. This method achieves high drug-loading efficiency, minimizing adverse effects on non-cancerous cells, making it more effective for treating cancerous tissues.
What are the future prospects of aptamer-targeted delivery systems?
Aptamer-targeted delivery systems show great potential for advanced cancer treatments due to their high specificity and low immunogenicity. As research advances, it is expected that these systems will lead to improved therapeutic efficacy and reduced side effects in various cancers.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Applications of aptamers in drug delivery system”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Cancer:
Cancer refers to a group of diseases characterized by uncontrolled cell growth and division, leading to the formation of tumors that can invade other tissues. Cancer diagnostics and targeted therapies, such as those utilizing aptamers, are crucial for accurate disease detection and treatment options, aiming to improve patient outcomes.
2) Drug:
Drugs are substances used to diagnose, treat, or prevent diseases. In the context of cancer, targeted drug delivery systems, particularly those employing aptamers, are developed to enhance the efficacy and reduce side effects of treatments, allowing for more effective therapeutic interventions in patients.
3) Gold (Golden):
Gold is a metal that is significant in biomedical applications, especially as a nanoparticle for drug delivery. Gold nanoparticles (AuNPs) can be used in conjunction with aptamers for targeted therapy and diagnostics, demonstrating advantages such as biocompatibility, ease of functionalization, and strong optical properties.
4) Surface:
In drug delivery, the surface of nanoparticles, including those functionalized with aptamers, is crucial for determining interactions with target cells. Surface modification allows for enhanced binding specificity and targeting capabilities, making it easier to deliver therapeutics directly to cancer cells while minimizing impacts on healthy cells.
5) Evolution:
Evolution in this context refers to the process used to develop aptamers through SELEX (systematic evolution of ligands by exponential enrichment). This laboratory technique allows for the selection of high-affinity sequences from vast libraries, leading to advancements in targeted drug delivery and diagnostic applications.
6) Cina:
China is mentioned as the location of the Key Laboratory of Modern Chinese Medicines, where the authors and researchers are based. The ongoing research in this country contributes to the global understanding of aptamers and their applications in drug delivery systems, enhancing pharmaceutical development.
7) Medicine:
Medicine encompasses the science and practice of diagnosing, treating, and preventing diseases. The application of aptamers in drug delivery and cancer diagnostics illustrates the intersection of biochemistry and medicine, aiming for innovative solutions to enhance therapeutic efficacy and patient care.
8) Line:
In the context of the article, 'line' often refers to specific cancer cell lines used for experiments. Understanding how aptamer-drug conjugates affect various cell lines helps researchers to optimize targeted drug delivery systems and assess the potential efficacy of therapies before clinical application.
9) Disease:
Disease generally pertains to any condition that impairs normal functioning, including cancer. The methodologies and innovations discussed, such as aptamers in diagnosis and treatment, aim to address significant diseases and improve therapeutic strategies, ultimately benefiting patient health and disease management.
10) Field:
The field relates to cancer research and drug delivery sciences. This area is rapidly evolving, with scientists exploring novel therapeutic approaches and diagnostic tools, like aptamers, to improve cancer treatment outcomes and contribute to advancing biomedical research.
11) Chemotherapy:
Chemotherapy is a common treatment modality for cancer that uses drugs to kill cancer cells or inhibit their growth. Aptamers can enhance the specificity of chemotherapeutic agents, ensuring that drugs target cancer cells more effectively, while minimizing toxicity to normal cells.
12) Vaishali (Vaisali):
Vaishali refers to one of the researchers mentioned in the paper, contributing to the study of aptamer-drug systems. Individual contributions like hers help further the understanding of drug delivery mechanisms, especially in the context of targeted therapies for cancer treatment.
13) Toxicity:
Toxicity refers to the degree to which a substance can harm living organisms. In cancer therapy, minimizing toxicity is essential, as it can lead to adverse effects. Utilizing aptamer-drug conjugates aims to reduce toxicity by ensuring selectivity for cancerous tissues over normal cells.
14) Killing (Killed):
Killing describes the main objective of many cancer therapies, which is to eliminate cancer cells. The use of targeted delivery systems, like those utilizing aptamers, aims to enhance the killing of malignant cells while sparing healthy tissues, thereby improving therapeutic effectiveness.
15) Purity:
Purity indicates the quality of the aptamers and drugs used in research and treatments. High purity ensures that the active molecules used in drug delivery systems are effective and free from impurities that could negatively impact efficacy or introduce unwanted toxicity.
16) Shirna (Sirna):
siRNA (small interfering RNA) is a type of RNA that plays a role in gene silencing and can be utilized in targeted therapy. The integration of siRNA with aptamer-based drug delivery systems is a promising approach to downregulate oncogenes and improve cancer treatment outcomes.
17) Water:
Water is a crucial component in biological systems and drug formulation, influencing solubility and delivery of therapeutic agents. In hydrogels, which can be used for targeted drug delivery, water content plays a vital role in drug release profiles and biocompatibility.
18) Blood:
Blood is essential in cancer diagnostics and therapy because it can serve as a medium for detecting cancer biomarkers. Aptamers can facilitate the identification of specific proteins or cells in the bloodstream, improving early cancer detection methods and treatment monitoring.
19) Life:
Life signifies the intricate processes and systems of living organisms, which cancer disrupts. Advancements in drug delivery and diagnostics, particularly through the use of aptamers, aim to enhance the quality of life for patients battling cancer and other diseases.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Applications of aptamers in drug delivery system’. Further sources in the context of Science might help you critically compare this page with similair documents:
Colorimetric assay, Molecular recognition, Molecular probes, Early diagnosis of cancer.